Oroxylin A

Oroxylin A is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 747 references associated with Oroxylin A in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Oroxylin A

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Oroxylin A

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Seizures D012640 87 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Per page 10 20 | Total 12

NCBI Entrez Crosslinks

All references with Oroxylin A

Download all related citations
Per page 10 20 50 100 | Total 124
Authors Title Published Journal PubMed Link
Zhang Q et al. Determination of oroxylin A and oroxylin A 7-O-d-glucuronide in HepG2 cell lysate and subcellular fractions with SPE-UPLC-MS/MS: Cellular pharmacokinetic study to indicate anti-cancer mechanisms. 2018 J Pharm Biomed Anal pmid:29571134
Chen W et al. Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation. 2018 Int. Immunopharmacol. pmid:29414645
Jin H et al. Oroxylin A inhibits ethanol-induced hepatocyte senescence via YAP pathway. 2018 Cell Prolif. pmid:29318697
Jin J et al. Oroxylin A suppresses influenza A virus replication correlating with neuraminidase inhibition and induction of IFNs. 2018 Biomed. Pharmacother. pmid:29091888
Wu SC et al. Baicalin protects mice against Salmonella typhimurium infection via the modulation of both bacterial virulence and host response. 2018 Phytomedicine pmid:30195877
Zhang C et al. Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF-1α signaling. 2018 J. Cell. Biochem. pmid:28857294
Shimizu T et al. Synergistic effect of baicalein, wogonin and oroxylin A mixture: multistep inhibition of the NF-κB signalling pathway contributes to an anti-inflammatory effect of Scutellaria root flavonoids. 2018 J Nat Med pmid:28921127
Jin H et al. Oroxylin A prevents alcohol-induced hepatic steatosis through inhibition of hypoxia inducible factor 1alpha. 2018 Chem. Biol. Interact. pmid:29476730
Chassagne F et al. A metabolomic approach to identify anti-hepatocarcinogenic compounds from plants used traditionally in the treatment of liver diseases. 2018 Fitoterapia pmid:29477305
Zhang R et al. Catechol-O-Methyltransferase and UDP-Glucuronosyltransferases in the Metabolism of Baicalein in Different Species. 2017 Eur J Drug Metab Pharmacokinet pmid:28536775
Fong SYK et al. Brain Uptake of Bioactive Flavones in Scutellariae Radix and Its Relationship to Anxiolytic Effect in Mice. 2017 Mol. Pharm. pmid:28426226
Mangal P et al. Screening of six Ayurvedic medicinal plants for anti-obesity potential: An investigation on bioactive constituents from Oroxylum indicum (L.) Kurz bark. 2017 J Ethnopharmacol pmid:27469197
Chen M et al. Simultaneous determination of wogonin, oroxylin a, schisandrin, paeoniflorin and emodin in rat serum by HPLC-MS/MS and application to pharmacokinetic studies. 2017 Biomed. Chromatogr. pmid:28236316
Han Q et al. Oroxylin A inhibits HO-induced oxidative stress in PC12 cells. 2017 Nat. Prod. Res. pmid:27820974
Tan C et al. Oroxylin a could be a Promising Radiosensitizer for Esophageal Squamous Cell Carcinoma by Inducing G2/M Arrest and Activating Apoptosis. 2017 Pathol. Oncol. Res. pmid:27585443
Li W et al. Oroxylin A reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12/CXCR7 axis in bone marrow microenvironment. 2017 Mol. Carcinog. pmid:27533597
Lin SF et al. Oroxylin A promotes retinal ganglion cell survival in a rat optic nerve crush model. 2017 PLoS ONE pmid:28640893
Wei L et al. Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression. 2017 Cell Death Dis pmid:28726775
Ni T et al. Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolism. 2017 Cell Death Dis pmid:28594405
Shen L et al. Oroxylin A inhibits the generation of Tregs in non-small cell lung cancer. 2017 Oncotarget pmid:28472762
Fu X et al. A general strategy for the synthesis of homogeneous hyaluronan conjugates and their biological applications. 2017 Chem. Commun. (Camb.) pmid:28286894
Yu H et al. Enhancement of solubility and dissolution rate of baicalein, wogonin and oroxylin A extracted from Radix scutellariae. 2017 Int J Pharm pmid:28642200
Liu RX et al. Distribution patterns of the contents of five biologically activate ingredients in the root of Scutellaria baicalensis. 2017 Chin J Nat Med pmid:28284428
Zhang YY et al. Enzymatic production of oroxylin A and hispidulin using a liverwort flavone 6-O-methyltransferase. 2016 FEBS Lett. pmid:27432544
Lu L et al. Overview of Oroxylin A: A Promising Flavonoid Compound. 2016 Phytother Res pmid:27539056
Li J et al. Oroxylin A attenuates cigarette smoke-induced lung inflammation by activating Nrf2. 2016 Int. Immunopharmacol. pmid:27764743
Wang YL et al. Therapeutic potential of Oroxylin A in rheumatoid arthritis. 2016 Int. Immunopharmacol. pmid:27643663
Hui H et al. Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells. 2016 J. Cancer Res. Clin. Oncol. pmid:27085528
Qiao C et al. Oroxylin A modulates mitochondrial function and apoptosis in human colon cancer cells by inducing mitochondrial translocation of wild-type p53. 2016 Oncotarget pmid:26958937
Zhou DG et al. Oroxylin A Inhibits Allergic Airway Inflammation in Ovalbumin (OVA)-Induced Asthma Murine Model. 2016 Inflammation pmid:26895180
Wei L et al. Oroxylin A inhibits invasion and migration through suppressing ERK/GSK-3β signaling in snail-expressing non-small-cell lung cancer cells. 2016 Mol. Carcinog. pmid:26741501
Dai Q et al. Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells. 2016 Mol. Carcinog. pmid:26259145
Huang L et al. Application of a new method, orthogonal projection to latent structure (OPLS) combined with principal component analysis (PCA), to screening of prostaglandin E2 production inhibitory flavonoids in Scutellaria Root. 2016 J Nat Med pmid:27164908
Kwon BE et al. Antiviral Activity of Oroxylin A against Coxsackievirus B3 Alleviates Virus-Induced Acute Pancreatic Damage in Mice. 2016 PLoS ONE pmid:27195463
Yang H et al. Drug activity screening based on microsomes-hydrogel system in predicting metabolism induced antitumor effect of oroxylin A. 2016 Sci Rep pmid:26905263
Tseng TL et al. Induction of endothelium-dependent constriction of mesenteric arteries in endotoxemic hypotensive shock. 2016 Br. J. Pharmacol. pmid:26694894
Cho P et al. Effects of Lead Phytochemicals of Radix Scutellariae on Acanthamoeba. 2016 Invest. Ophthalmol. Vis. Sci. pmid:27918833
Huang H et al. Protective effect of oroxylin A against lipopolysaccharide and/or D-galactosamine-induced acute liver injury in mice. 2015 J. Surg. Res. pmid:25818981
Qiao C et al. UCP2-related mitochondrial pathway participates in oroxylin A-induced apoptosis in human colon cancer cells. 2015 J. Cell. Physiol. pmid:25251374
Zou M et al. Oroxylin A induces autophagy in human malignant glioma cells via the mTOR-STAT3-Notch signaling pathway. 2015 Mol. Carcinog. pmid:25213258
Li X et al. Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway. 2015 Arch. Toxicol. pmid:24671465
Zhao K et al. Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells. 2015 J Hematol Oncol pmid:25902914
Wei L et al. Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1α destabilization. 2015 Cell Death Dis pmid:25855962
Li C et al. Influence of mefenamic acid on the intestinal absorption and metabolism of three bioactive flavones in Radix Scutellariae and potential pharmacological impact. 2014 Pharm Biol pmid:24102566
Fong SY et al. Development of a SPE-LC/MS/MS method for simultaneous quantification of baicalein, wogonin, oroxylin A and their glucuronides baicalin, wogonoside and oroxyloside in rats and its application to brain uptake and plasma pharmacokinetic studies. 2014 J Pharm Biomed Anal pmid:24803030
Fong SY and Zuo Z Species difference in the inhibitory potentials of non-steroidal anti-inflammatory drugs on the hepatic sulfation and glucuronidation of bioactive flavonoids: differential observations among common inhibition parameters. 2014 Xenobiotica pmid:24168065
Singh J and Kakkar P Oroxylin A, a constituent of Oroxylum indicum inhibits adipogenesis and induces apoptosis in 3T3-L1 cells. 2014 Phytomedicine pmid:25442284
Ye M et al. Oroxylin A exerts anti-inflammatory activity on lipopolysaccharide-induced mouse macrophage via Nrf2/ARE activation. 2014 Biochem. Cell Biol. pmid:25247252
Kim DH et al. Oroxylin A enhances memory consolidation through the brain-derived neurotrophic factor in mice. 2014 Brain Res. Bull. pmid:25218897
Hui H et al. Oroxylin A inhibits ATRA-induced IL-6 expression involved in retinoic acid syndrome by down-regulating CHOP. 2014 Gene pmid:25192658
Cheng Y et al. Oroxylin A inhibits hypoxia-induced invasion and migration of MCF-7 cells by suppressing the Notch pathway. 2014 Anticancer Drugs pmid:24637576
Ku SK et al. Antithrombotic activities of oroxylin A in vitro and in vivo. 2014 Arch. Pharm. Res. pmid:23963976
Yao J et al. Oroxylin A prevents inflammation-related tumor through down-regulation of inflammatory gene expression by inhibiting NF-κB signaling. 2014 Mol. Carcinog. pmid:22949302
Ku SK et al. Inhibitory effects of oroxylin A on endothelial protein C receptor shedding in vitro and in vivo. 2014 BMB Rep pmid:24286327
Hui H et al. Oroxylin A has therapeutic potential in acute myelogenous leukemia by dual effects targeting PPARγ and RXRα. 2014 Int. J. Cancer pmid:23934681
Wang Y et al. CXCL12/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562/ADM cells. 2014 Biochem. Pharmacol. pmid:24858801
Zhu L et al. Oroxylin A reverses P-glycoprotein-mediated multidrug resistance of MCF7/ADR cells by G2/M arrest. 2013 Toxicol. Lett. pmid:23470866
Wei L et al. Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: c-Src and hexokinase II. 2013 Biochim. Biophys. Acta pmid:23500080
Yang X et al. Oroxylin A inhibits colitis-associated carcinogenesis through modulating the IL-6/STAT3 signaling pathway. 2013 Inflamm. Bowel Dis. pmid:23823704
Wei L et al. Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma. 2013 Cell Death Dis pmid:23598413
Dong J et al. Oroxylin A inhibits hemolysis via hindering the self-assembly of α-hemolysin heptameric transmembrane pore. 2013 PLoS Comput. Biol. pmid:23349625
Yoon SY et al. Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro. 2013 Arch. Pharm. Res. pmid:23371806
Liu X et al. The ameliorating effects of 5,7-dihydroxy-6-methoxy-2(4-phenoxyphenyl)-4H-chromene-4-one, an oroxylin A derivative, against memory impairment and sensorimotor gating deficit in mice. 2013 Arch. Pharm. Res. pmid:23543630
dela Peña IC et al. 5,7-Dihydroxy-6-methoxy-4'-phenoxyflavone, a derivative of oroxylin A improves attention-deficit/hyperactivity disorder (ADHD)-like behaviors in spontaneously hypertensive rats. 2013 Eur. J. Pharmacol. pmid:23707903
Wang H et al. An estrogen receptor dependent mechanism of Oroxylin A in the repression of inflammatory response. 2013 PLoS ONE pmid:23922737
Zhu R et al. Oroxylin A accelerates liver regeneration in CClâ‚„-induced acute liver injury mice. 2013 PLoS ONE pmid:23951204
Dai Q et al. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells. 2013 Int. J. Biochem. Cell Biol. pmid:23612020
Qiu J et al. Molecular modeling reveals the novel inhibition mechanism and binding mode of three natural compounds to staphylococcal α-hemolysin. 2013 PLoS ONE pmid:24312202
Kim DH et al. 4'-bromo-5,6,7-trimethoxyflavone represses lipopolysaccharide-induced iNOS and COX-2 expressions by suppressing the NF-κB signaling pathway in RAW 264.7 macrophages. 2012 Bioorg. Med. Chem. Lett. pmid:22101131
Yang HY et al. Oroxylin A reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-κB signaling pathway. 2012 Mol. Carcinog. pmid:21557331
Zou M et al. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling. 2012 Cell. Signal. pmid:22560876
Hu R et al. The role of Nrf2 and apoptotic signaling pathways in oroxylin A-mediated responses in HCT-116 colorectal adenocarcinoma cells and xenograft tumors. 2012 Anticancer Drugs pmid:22526619
Ha J et al. Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway. 2012 Biochem. Cell Biol. pmid:22607196
Xu M et al. Activation of the unfolded protein response contributed to the selective cytotoxicity of oroxylin A in human hepatocellular carcinoma HepG2 cells. 2012 Toxicol. Lett. pmid:22609744
Lu Z et al. Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway. 2012 Toxicol. Lett. pmid:22245252
Zhu B et al. Oroxylin A reverses CAM-DR of HepG2 cells by suppressing Integrinβ1 and its related pathway. 2012 Toxicol. Appl. Pharmacol. pmid:22310179
Fu W et al. Synthesis and biological evaluation of 7-O-modified oroxylin A derivatives. 2012 Bioorg. Med. Chem. Lett. pmid:22196122
Tong L et al. Simultaneous determination of baicalin, wogonoside, baicalein, wogonin, oroxylin A and chrysin of Radix scutellariae extract in rat plasma by liquid chromatography tandem mass spectrometry. 2012 J Pharm Biomed Anal pmid:22703838
Pham TA et al. Oroxylin A analogs exhibited strong inhibitory activities against iNOS-mediated nitric oxide (NO) production. 2012 Bioorg. Med. Chem. Lett. pmid:22366656
Wang H et al. [Vasodilator effect of oroxylin A on thoracic aorta isolated from rats]. 2012 Zhong Xi Yi Jie He Xue Bao pmid:22883404
Song X et al. Oroxylin A, a classical natural product, shows a novel inhibitory effect on angiogenesis induced by lipopolysaccharide. 2012 Pharmacol Rep pmid:23238475
Liu PW et al. STAT1 mediates oroxylin a inhibition of iNOS and pro-inflammatory cytokines expression in microglial BV-2 cells. 2012 PLoS ONE pmid:23236370
Guo H et al. [Preparation of flavonoid reference standards from Scutellariae Radix under the guidance of high performance liquid chromatography-mass spectrometry analysis]. 2012 Se Pu pmid:23189664
Tseng TL et al. Oroxylin-A rescues LPS-induced acute lung injury via regulation of NF-κB signaling pathway in rodents. 2012 PLoS ONE pmid:23071799
Lu QY et al. Detection of baicalin metabolites baicalein and oroxylin-a in mouse pancreas and pancreatic xenografts. 2012 Pancreas pmid:22158070
Li C et al. Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix Scutellariae. 2012 AAPS J pmid:22167378
Jeon SJ et al. Oroxylin A increases BDNF production by activation of MAPK-CREB pathway in rat primary cortical neuronal culture. 2011 Neurosci. Res. pmid:21145362
Li C et al. Identification and quantification of baicalein, wogonin, oroxylin A and their major glucuronide conjugated metabolites in rat plasma after oral administration of Radix scutellariae product. 2011 J Pharm Biomed Anal pmid:21051171
Lee S et al. Oroxylin A, a flavonoid, stimulates adult neurogenesis in the hippocampal dentate gyrus region of mice. 2010 Neurochem. Res. pmid:20680459
Zhao L et al. Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice. 2010 Cancer Chemother. Pharmacol. pmid:19585117
Gao Y et al. Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation. 2010 J. Cancer Res. Clin. Oncol. pmid:19888602
Zhou Q et al. Use of isoform-specific UGT metabolism to determine and describe rates and profiles of glucuronidation of wogonin and oroxylin A by human liver and intestinal microsomes. 2010 Pharm. Res. pmid:20411407
Marques MR et al. Flavonoids with prolyl oligopeptidase inhibitory activity isolated from Scutellaria racemosa Pers. 2010 Fitoterapia pmid:20117183
Kumar GS et al. Synthesis and biological evaluation of novel benzyl-substituted flavones as free radical (DPPH) scavengers and α-glucosidase inhibitors. 2010 J Asian Nat Prod Res pmid:21061220
Trinh HT et al. Anti-pruritic effect of baicalin and its metabolites, baicalein and oroxylin A, in mice. 2010 Acta Pharmacol. Sin. pmid:20453872
Shih HC et al. In vitro study of the tocolytic effect of oroxylin A from Scutellaria baicalensis root. 2009 J. Biomed. Sci. pmid:19272127
Go WJ et al. Evaluation of the flavonoid oroxylin A as an inhibitor of P-glycoprotein-mediated cellular efflux. 2009 J. Nat. Prod. pmid:19739602
Li HN et al. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo. 2009 Toxicology pmid:19135124
Li J et al. Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora. 2009 J. Nat. Prod. pmid:19555121
Zhou XQ et al. [Flavonoids from Scutellaria baicalensis and their bioactivities]. 2009 Beijing Da Xue Xue Bao pmid:19829679